Format

Send to

Choose Destination
Nat Rev Rheumatol. 2020 Mar;16(3):155-166. doi: 10.1038/s41584-020-0372-x. Epub 2020 Feb 7.

Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology.

Author information

1
Department of Nephrology and Intensive Medical Care, Charité-Universitätsmedizin Berlin, Berlin, Germany.
2
Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany. thomas.doerner@charite.de.
3
Deutsches Rheumaforschungszentrum (DRFZ), Berlin, Germany. thomas.doerner@charite.de.

Abstract

Despite widespread clinical use of antimalarial drugs such as hydroxychloroquine and chloroquine in the treatment of rheumatoid arthritis (RA), systemic lupus erythematosus (SLE) and other inflammatory rheumatic diseases, insights into the mechanism of action of these drugs are still emerging. Hydroxychloroquine and chloroquine are weak bases and have a characteristic 'deep' volume of distribution and a half-life of around 50 days. These drugs interfere with lysosomal activity and autophagy, interact with membrane stability and alter signalling pathways and transcriptional activity, which can result in inhibition of cytokine production and modulation of certain co-stimulatory molecules. These modes of action, together with the drug's chemical properties, might explain the clinical efficacy and well-known adverse effects (such as retinopathy) of these drugs. The unknown dose-response relationships of these drugs and the lack of definitions of the minimum dose needed for clinical efficacy and what doses are toxic pose challenges to clinical practice. Further challenges include patient non-adherence and possible context-dependent variations in blood drug levels. Available mechanistic data give insights into the immunomodulatory potency of hydroxychloroquine and provide the rationale to search for more potent and/or selective inhibitors.

PMID:
32034323
DOI:
10.1038/s41584-020-0372-x

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center